Wafik El-Deiry: These are fond memories as time flies by and the field advances
Wafik El-Deiry recently shared on LinkedIn:
“Ten years ago at the 50th American Society of Clinical Oncology (ASCO) meeting, ASCO14, I presented results from a collaboration with Caris Life Sciences from when I was Chief of Hem-Onc at Penn State University, congratulated Mala Talekar (now VP Clinical Development at Verismo Therapeutics) who I mentored at Penn State College of Medicine for a Conquer Cancer, the ASCO Foundation award, and spoke with the late Joseph Bertino, American Cancer Society Professor, past-President of ASCO (1975), past-President of American Association for Cancer Research (1995).
These are fond memories as time flies by and the field advances.”
Source: Wafik El-Deiry/LinkedIn
Wafik El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School, and Director of the Legorreta Cancer Center at Brown University, and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals. Dr.
El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry made important contributions to cell death signaling and our understanding of the sensitivity of tumors to chemotherapy. El-Deiry has more than 400 peer-reviewed publications and 5 edited books.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023